Hangzhou AGS MedTech Co Ltd
SSE:688581
Cash Flow Statement
Cash Flow Statement
Hangzhou AGS MedTech Co Ltd
| Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Stock-Based Compensation |
2
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
(42)
|
(44)
|
(51)
|
(70)
|
(72)
|
(75)
|
(77)
|
(78)
|
|
| Change in Working Capital |
(112)
|
(102)
|
(109)
|
(138)
|
(131)
|
(154)
|
(171)
|
(189)
|
|
| Cash from Operating Activities |
221
N/A
|
225
+2%
|
268
+19%
|
368
+37%
|
316
-14%
|
309
-2%
|
275
-11%
|
219
-20%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(52)
|
(50)
|
(51)
|
(62)
|
(50)
|
(41)
|
(47)
|
(69)
|
|
| Other Items |
(25)
|
0
|
(1 049)
|
(1 296)
|
(1 081)
|
(1 045)
|
123
|
151
|
|
| Cash from Investing Activities |
(77)
N/A
|
(76)
+1%
|
(1 101)
-1 355%
|
(1 357)
-23%
|
(1 130)
+17%
|
(1 087)
+4%
|
76
N/A
|
81
+7%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
1 820
|
0
|
0
|
0
|
6
|
0
|
0
|
13
|
|
| Cash Paid for Dividends |
(44)
|
0
|
(127)
|
(127)
|
(83)
|
0
|
0
|
(111)
|
|
| Other |
(179)
|
(199)
|
(37)
|
(37)
|
(32)
|
(11)
|
12
|
14
|
|
| Cash from Financing Activities |
1 598
N/A
|
1 577
-1%
|
(164)
N/A
|
(164)
N/A
|
(109)
+33%
|
(89)
+19%
|
18
N/A
|
(85)
N/A
|
|
| Change in Cash | |||||||||
| Effect of Foreign Exchange Rates |
1
|
2
|
1
|
(1)
|
0
|
0
|
(0)
|
0
|
|
| Net Change in Cash |
1 743
N/A
|
1 728
-1%
|
(996)
N/A
|
(1 155)
-16%
|
(924)
+20%
|
(866)
+6%
|
369
N/A
|
216
-41%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
170
N/A
|
175
+3%
|
216
+24%
|
306
+42%
|
266
-13%
|
268
+1%
|
228
-15%
|
150
-34%
|
|